Filing Details
- Accession Number:
- 0001562180-25-002735
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-25 16:31:23
- Reporting Period:
- 2025-03-24
- Filing Date:
- 2025-03-25
- Accepted Time:
- 2025-03-25 16:31:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1324863 | G Tommy Thompson | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-24 | 2,500 | $175.43 | 10,980 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-03-24 | 2,500 | $318.80 | 8,480 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2025-03-24 | 2,500 | $0.00 | 2,500 | $175.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2016-06-26 | 2025-06-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,200 | Indirect | by Trust |
Common Stock | 5,800 | Indirect | Family LLC |
Footnotes
- Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
- This transaction was executed in multiple trades at prices ranging from $318.43 to $319.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.